Genital herpes vaccine promising in animal studies
Key points
- A vaccine based on a genetically modified strain of herpes simplex virus 2 - the type usually responsible for genital infections - rapidly induces an immune response in mice and guinea pigs, researchers report.
- Straus of Harvard Medical School, Boston and colleagues developed the vaccine, dubbed dl5-29, in which they deleted genes from the virus so that it could not replicate.
- In test animals, both dl15-29 and the gD2 vaccine were highly effective in reducing the severity of acute herpes infections and recurrent episodes, as well as in lowering the amount of latent virus the animals harbored, according to the team's report in the Journal of Virology.
- However, dl5-29 was superior to the gD2 vaccine in producing the level of antibodies needed to neutralize the herpes virus.
A vaccine based on a genetically modified strain of herpes simplex virus 2 - the type usually responsible for genital infections - rapidly induces an immune response in mice and guinea pigs, researchers report.
Dr. Stephen E. Straus of Harvard Medical School, Boston and colleagues developed the vaccine, dubbed dl5-29, in which they deleted genes from the virus so that it could not replicate. The researchers then compared the performance of this novel vaccine with that of another type of herpes vaccine (gD2), which has already been tested in humans.
In test animals, both dl15-29 and the gD2 vaccine were highly effective in reducing the severity of acute herpes infections and recurrent episodes, as well as in lowering the amount of latent virus the animals harbored, according to the team's report in the Journal of Virology.
However, dl5-29 was superior to the gD2 vaccine in producing the level of antibodies needed to neutralize the herpes virus.
"Based upon dl15-29's biological and immunological properties," Straus comments in a statement, "it appears to be the most compelling new vaccine candidate for genital herpes."
SOURCE: Journal of Virology, January 2005.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Lungs, Asthma & Allergies →NewsYale researchers beat untreatable eczema with arthritis drug
Researchers at Yale School of Medicine have successfully treated patients with moderate to severe eczema using a rheumatoid arthritis drug recently shown to reverse two other disfiguring skin conditions, vitiligo and…
21 July 2015
NewsHow the lung repairs its wounds
According to the World Health Organization (WHO), lung diseases are the third most common cause of death worldwide: toxic particles, infections, and chronic inflammatory responses pose a permanent threat to our lungs.…
15 July 2015
NewsThe role of the microbiota in preventing allergies
The human body is inhabited by billions of symbiotic bacteria, carrying a diversity that is unique to each individual. The microbiota is involved in many mechanisms, including digestion, vitamin synthesis and host…